Oct 2026· Diabetes, obesity and metabolism· 0 citations· 32 references
Medicine
TL;DR
CMDs are highly interrelated, and obesity plays a central role in bridging CMDs in the longitudinal networks, highlighting its relevance to both individual CMDs and their clustering as cardiometabolic multimorbidity.
Abstract
Aims
To explore longitudinal and bidirectional associations between obesity and cardiometabolic diseases (CMDs) using a cross-lagged panel network (CLPN) framework in three nationally representative Chinese cohorts.
Materials And Methods
We analysed participants aged 45 years and older from CHARLS (2011-2015; n = 12 491), CHNS (2004-2015; n = 8412) and CFPS (2010-2022; n = 22 193). A CLPN model was used to estimate bidirectional longitudinal associations between obesity and CMDs between participant-specific first and last eligible surveys. CMDs included hypertension (HBP), diabetes (DM), ischaemic heart disease (IHD) and cerebrovascular disease (CVD). Network replicability was assessed across cohorts.
Results
Across cohorts, 3.43%-5.49% of participants transitioned from non-obese to obese status, while 16.44%-26.03% transitioned from no CMD to CMD status. Three networks showed moderate structural similarity, with 12 directionally concordant obesity-CMD edges and moderate edge-weight correlations (r = 0.59-0.64; all p < 0.01). The obesity-to-diabetes edge was the strongest directed association in CHARLS (OR 2.59, 95% CI:2.18-3.11) and CFPS (2.77, 2.31-3.29), and the second strongest in CHNS (3.43, 2.67-4.31). Among obesity-originating edges, the same rank order (diabetes, hypertension, IHD and CVD) was observed across cohorts. Obesity showed the highest out-expected influence and the lowest in-expected influence. A positive hypertension-to-obesity association and bidirectional hypertension-diabetes associations were consistently observed.
Conclusions
CMDs are highly interrelated, and obesity plays a central role in bridging CMDs in the longitudinal networks, highlighting its relevance to both individual CMDs and their clustering as cardiometabolic multimorbidity.
Cardiometabolic multimorbidity (CMM) is an increasing public health challenge in aging populations. The cholesterol–high-density lipoprotein–glucose (CHG) index is an emerging metabolic marker, but its association with prevalent CMM has not been sufficiently evaluated across community and hospitalized populations....
Ze-Xu Cui, Tian-Hao Lan, Min-Chin Lu et al.· Frontiers in Public Health· 0 citations
TyG BA composites provide a parsimonious summary of combined metabolic-aging burden and improve risk discrimination beyond conventional clinical factors, but should not be interpreted as superior to models retaining TyG and biological age separately.
BACKGROUND
The cardiometabolic index (CMI), a composite marker derived from the product of waist-to-height ratio and triglyceride-to- high-density lipoprotein cholesterol ratio, has emerged as a potential indicator of metabolic risk. However, the prognostic value of the CMI across diverse populations and the continuum...
Zhen-Yu Liu, Zhi-Xin Li, Si-Yan Huo et al.· Heart, Lung and Circulation· 0 citations
Cardiometabolic multimorbidity (CMM) is an increasing public health concern in ageing populations. Although individual residential environmental factors have been linked to cardiometabolic health, the association of multidimensional living environmental quality with incident CMM remains unclear. We aimed to const...
Hao Chen, Sheng-Nan Yue, Sheng-Yan Hou et al.· BMC Public Health· 0 citations
Poorer functional mobility was associated with CMM among middle-aged and older adults in China in both cross-sectional and longitudinal analyses and simple functional assessments may help characterize groups with greater cardiometabolic burden and may be useful in clinical assessment and monitoring in ageing population...
Shu-Han Guo· Journal of Multimorbidity an...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.